BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.
- DOI
- 10.1158/2767-9764.crc-25-0638
- Published
- 2026 May 1
- Container
- Cancer research communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2767-9764.crc-25-0638,
title = {BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.},
author = {Harding JJ and Hofheinz R and Élez E and Kuboki Y and Rasco DW and Cecchini M and Shen L and He M and Archuadze S and Chhaya N and Haderk F and Mészáros L and Wölke S and Katakabe T and Lorence RM and Van Cutsem E and Kopetz S and Pant S},
year = {2026},
journal = {Cancer research communications},
doi = {10.1158/2767-9764.crc-25-0638},
url = {https://doi.org/10.1158/2767-9764.crc-25-0638}
}RIS
TY - JOUR TI - BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings. AU - Harding JJ AU - Hofheinz R AU - Élez E AU - Kuboki Y AU - Rasco DW AU - Cecchini M AU - Shen L AU - He M AU - Archuadze S AU - Chhaya N AU - Haderk F AU - Mészáros L AU - Wölke S AU - Katakabe T AU - Lorence RM AU - Van Cutsem E AU - Kopetz S AU - Pant S PY - 2026 JO - Cancer research communications DO - 10.1158/2767-9764.crc-25-0638 UR - https://doi.org/10.1158/2767-9764.crc-25-0638 ER -
APA
JJ, H., R, H., E, É., Y, K., DW, R., M, C., L, S., M, H., S, A., N, C., F, H., L, M., S, W., T, K., RM, L., E, V. C., S, K., & S, P. (2026). BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-25-0638
Source records
- pubmed · retrieved 2026-09-26T09:44:32.031Z